Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lijing Xu

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Foods (Basel, Switzerland)|January 23, 2024
The Effects of <i>Naematelia aurantialba</i> on the Pasting and Rheological Properties of Starch and the Research and Development of Soft CandyYanfen Cheng, Cuixin Su, Shijie Wei, et al.
Carcinogenesis|January 8, 2009
Chemical genomics of cancer chemopreventive dithiolethionesQuynh T Tran, Lijing Xu, Vinhthuy Phan, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
Biological activity and preclinical efficacy of azetidinyl pyridazines as potent systemically-distributed stearoyl-CoA desaturase inhibitorsElise Isabel, David A Powell, W Cameron Black, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
The development of potent non-peptidic PTP-1B inhibitorsClaude Dufresne, Patrick Roy, Zhaoyin Wang, et al.
Molecular Cancer Therapeutics|January 9, 2003
Multiple comparisons model-based clustering and ternary pattern tree numerical display of gene response to treatment: procedure and application to the preclinical evaluation of chemopreventive agentsThomas R Sutter, Xiao-Rui He, Peter Dimitrov, et al.
Bioorganic & Medicinal Chemistry Letters|October 24, 2002
Discovery of a potent and selective COX-2 inhibitor in the alkoxy lactone series with optimized metabolic profileYves Leblanc, Patrick Roy, Zhaoyin Wang, et al.
Bioorganic & Medicinal Chemistry Letters|April 22, 2011
Synthesis and SAR of pyrimidine-based, non-nucleotide P2Y14 receptor antagonistsDaniel Guay, Christian Beaulieu, Michel Belley, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 21, 2015
Neutrophil-Related Gene Expression and Low-Density Granulocytes Associated With Disease Activity and Response to Treatment in Antineutrophil Cytoplasmic Antibody-Associated VasculitisPeter C Grayson, Carmelo Carmona-Rivera, Lijing Xu, et al.
Journal of Medicinal Chemistry|June 14, 2011
Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemiaRenata M Oballa, Liette Belair, W Cameron Black, et al.
Nature Communications|May 12, 2025
Comprehensive molecular profiling of FH-deficient renal cell carcinoma identifies molecular subtypes and potential therapeutic targetsXingming Zhang, Junjie Zhao, Xiaoxue Yin, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Foods (Basel, Switzerland)|January 23, 2024
The Effects of <i>Naematelia aurantialba</i> on the Pasting and Rheological Properties of Starch and the Research and Development of Soft CandyYanfen Cheng, Cuixin Su, Shijie Wei, et al.
Carcinogenesis|January 8, 2009
Chemical genomics of cancer chemopreventive dithiolethionesQuynh T Tran, Lijing Xu, Vinhthuy Phan, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
Biological activity and preclinical efficacy of azetidinyl pyridazines as potent systemically-distributed stearoyl-CoA desaturase inhibitorsElise Isabel, David A Powell, W Cameron Black, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
The development of potent non-peptidic PTP-1B inhibitorsClaude Dufresne, Patrick Roy, Zhaoyin Wang, et al.
Molecular Cancer Therapeutics|January 9, 2003
Multiple comparisons model-based clustering and ternary pattern tree numerical display of gene response to treatment: procedure and application to the preclinical evaluation of chemopreventive agentsThomas R Sutter, Xiao-Rui He, Peter Dimitrov, et al.
Bioorganic & Medicinal Chemistry Letters|October 24, 2002
Discovery of a potent and selective COX-2 inhibitor in the alkoxy lactone series with optimized metabolic profileYves Leblanc, Patrick Roy, Zhaoyin Wang, et al.
Bioorganic & Medicinal Chemistry Letters|April 22, 2011
Synthesis and SAR of pyrimidine-based, non-nucleotide P2Y14 receptor antagonistsDaniel Guay, Christian Beaulieu, Michel Belley, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 21, 2015
Neutrophil-Related Gene Expression and Low-Density Granulocytes Associated With Disease Activity and Response to Treatment in Antineutrophil Cytoplasmic Antibody-Associated VasculitisPeter C Grayson, Carmelo Carmona-Rivera, Lijing Xu, et al.
Journal of Medicinal Chemistry|June 14, 2011
Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemiaRenata M Oballa, Liette Belair, W Cameron Black, et al.
Nature Communications|May 12, 2025
Comprehensive molecular profiling of FH-deficient renal cell carcinoma identifies molecular subtypes and potential therapeutic targetsXingming Zhang, Junjie Zhao, Xiaoxue Yin, et al.
Pageof 10